Company Filing History:
Years Active: 2016-2017
Title: The Innovations of Jonathan Sjögren
Introduction
Jonathan Sjögren is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of endoglycosidases. His work has implications for the understanding and manipulation of glycosylation in immunoglobulins.
Latest Patents
Jonathan holds a patent for an endoglycosidase known as EndoS49. This invention features a specific amino acid sequence and was isolated from strain NZ131. EndoS49 exhibits unique endoglycosidase activity on native IgG and is capable of cleaving a wider variety of Fc glycans compared to its homolog, EndoS. Additionally, a mutant version of EndoS49 was created, which lacks endoglycosidase activity but retains the ability to bind to IgG. The patent also discloses methods for using EndoS49 and its derivatives for assessing glycosylation of IgG or for isolating IgG.
Career Highlights
Throughout his career, Jonathan has worked with prominent companies in the biotechnology sector, including Genovis AB and Hansa Medical AB. His experience in these organizations has allowed him to further his research and development efforts in the field of glycosylation.
Collaborations
Jonathan has collaborated with several professionals in his field, including Mattias Collin and Maria Allhorn. These collaborations have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Jonathan Sjögren's innovative work in the field of endoglycosidases has the potential to significantly impact biochemistry and immunology. His contributions, particularly through his patent for EndoS49, highlight the importance of research in understanding glycosylation processes.